Emergingby GlyphXOMA Royalty agrees to acquire Generation Bio
The deal brings Generation Bio's cell-targeted LNP platform into XOMA's portfolio.
Nanotechnologysec.gov
XOMA Royalty
Public companyUS1 field
Where it works
| Technology | ||
|---|---|---|
| NanotechnologyRoyalty aggregator that agreed to buy Generation Bio and its ctLNP platform. | Royalty aggregator that agreed to buy Generation Bio and its ctLNP platform. | sec.gov |
Events
About
- Source
- sec.gov (filing, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Oct 6, 2026
- Across Glyph
- XOMA Royalty on Companies
XOMA Royalty
Joined in Nanotechnology. Royalty aggregator that agreed to buy Generation Bio and its ctLNP platform.
XOMA Royalty
Added in Nanotechnology. Royalty aggregator that agreed to buy Generation Bio and its ctLNP platform.